Literature DB >> 16470356

[Renal anemia - an important secondary disease in renal insufficiency].

C Mayer1, H Achenbach, M Stumvoll, G Fiedler.   

Abstract

Anemia is as a frequent complication in patients with chronic kidney disease, which gains in importance in the treatment of patients with renal disease. The main cause of renal anemia is the inadequately low production of endogenous erythropoietin. Often the patients develop an additional absolute or functional iron deficiency, which complicates the diagnostic and therapeutic procedures. Substitution of recombinant human erythropoietin (r-HuEPO) is the most effective therapy. The goal is a stable haemoglobin level >11 g/dl. An often additional existing iron deficiency should be balanced adequately according to the guidelines. With consequent and early treatment morbidity, mortality, and quality of life can be effectively improved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470356     DOI: 10.1007/s00108-006-1576-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  37 in total

1.  A hematologic "gold standard" for iron-deficient states?

Authors:  Carlo Brugnara
Journal:  Clin Chem       Date:  2002-07       Impact factor: 8.327

Review 2.  Anti-erythropoietin antibodies and pure red cell aplasia.

Authors:  Jerome Rossert; Nicole Casadevall; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

Review 3.  Hepcidin: a molecular link between inflammation and anaemia.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Nephrol Dial Transplant       Date:  2004-03       Impact factor: 5.992

Review 4.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

Review 5.  Anemia of chronic disease.

Authors:  Guenter Weiss; Lawrence T Goodnough
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

Review 6.  Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease.

Authors:  Madhumathi Rao; Brian J G Pereira
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

Review 7.  Managing a fateful alliance: anaemia and cardiovascular outcomes.

Authors:  Kai-Uwe Eckardt
Journal:  Nephrol Dial Transplant       Date:  2005-06       Impact factor: 5.992

8.  Anemia: an early complication of chronic renal insufficiency.

Authors:  W H Kazmi; A T Kausz; S Khan; R Abichandani; R Ruthazer; G T Obrador; B J Pereira
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

9.  Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.

Authors:  Walter H Hörl; Yves Vanrenterghem; Bernard Canaud; Johannes Mann; Ugo Teatini; Christoph Wanner; Björn Wikström
Journal:  Nephrol Dial Transplant       Date:  2005-05       Impact factor: 5.992

Review 10.  Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function.

Authors:  C Brugnara
Journal:  Crit Rev Clin Lab Sci       Date:  2000-04       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.